Is Waters Corporation (WAT) a Buy, Sell, or Hold?
NYSE : WAT
Waters Corporation
$367.55 USD
$10.01 (2.8%)
- Volume
- 988.82K
- Average Volume
- 1.02M
- Market Capitalization
- $23.96B
- P/E Ratio
- 46.64
- Dividend Yield
- 0.00%
- Price Target
- $405.00
- Year High
- $414.15
- Year Low
- $275.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.79
Company Overview
NYSE
Udit Batra
Medical - Diagnostics & Research
Healthcare
WAT
7900
US
USD
Liquidity Metrics
0.36
1.79
1.13
0.20
0.00
Sales & Valuation
$3.17B
6.35
1.97
90.75
3.21
Profitability
$10.76
$642.63M
11.91%
13.90%
8.04%
1.83%
P/E Metrics
46.64
-1.62
-1.62
Analyst Price Target & Rating
$405.00
$435.00
$350.00
3/5
35 Analysts
-9.25%
Financial Health Scores
2.48
3/9
$1.79B
$24.53B
$9.24B
$615.6M
Key Metrics (TTM)
$28.42B
7.54
30.74
1.79
8.04%
2.44%
1.53%
1.13%
$151.36
362 days
Company Executives
| Name | Title |
|---|---|
| Daniel Rush | Senior Vice President of Global Research & Strategy |
| Amol Chaubal | Senior Vice President & Chief Financial Officer |
| Brook Colangelo | Senior VP & Chief Information Officer |
| Cheryl Kennedy | Senior Vice President of Human Resources |
| Jianqing Y. Bennett | Senior Vice President of Waters Advanced Diagnostics |
| Kristen Garvey | Senior Vice President of Global Communications |
| Steve Conly | Senior Vice President of Waters Biosciences |
| Keeley A. Aleman | Senior VP, General Counsel & Head of Global Human Resources |
| Christos Ross | Senior Vice President of Global Operations |
| Caspar Tudor | Head of Investor Relations |
| Udit Batra | President, Chief Executive Officer & Director |
| Allan Jaenicke | Senior Vice President of Transformation |
| Robert L. Carpio | Senior Vice President of Waters Analytical Sciences |
Poll Results
No votes yet today — be the first to share your view!
About Waters Corporation (NYSE:WAT) Stock
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology ... plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
PitchBook Named Best Alternative Data Provider in Waters Technology Rankings 2026
2026-07-17 09:00:00
SEATTLE--(BUSINESS WIRE)--PitchBook, a leading private capital market intelligence platform, today announced it has been named “Best Alternative Data Provider” in the Waters Technology Rankings 2026. The award, presented by Waters Technology, a leading publication covering financial technology and data for global capital markets, was decided by crowd-sourced votes from industry professionals across the capital markets technology sector. The Waters Technology Rankings recognize service providers.
Waters Corporation Is Getting Awfully Pricey
2026-07-14 11:48:00
Waters Corporation remains a Hold as valuation concerns are balanced by ongoing synergy capture from its Becton, Dickinson acquisition. WAT's Q1 pro forma sales rose to $1.54B, with legacy revenue up 13% and recurring revenue surging 123%, signaling broad-based growth. Synergy realization is on track, with $55M+ cost savings and $50M revenue synergies targeted for 2026, supporting incremental EBITDA gains.
Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
2026-07-02 06:00:00
MILFORD, Mass., July 2, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m.
2026-06-24 08:00:00
LONDON--(BUSINESS WIRE)--IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, and Waters Corporation (NYSE: WAT) today announced a strategic partnership to accelerate the development of IMU's next-generation AI-powered High Definition (HD) Immunology platform.The partnership brings together Waters Biosciences' advanced flow cytometry and single-cell technologies,1 including BD FACSDiscover Cell Analyzer.
2026-06-09 08:00:00
Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%.
2026-06-08 08:00:00
Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory readiness.
Why Is Waters (WAT) Up 8.7% Since Last Earnings Report?
2026-06-04 12:35:43
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
2026-06-03 16:02:22
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Frequently Asked Questions
-
What is the current Waters Corporation (WAT) stock price?
-
Waters Corporation(NYSE:WAT) stock price is $367.55 in the last trading session. During the trading session, WAT stock reached the peak price of $414.15 while $275.05 was the lowest point it dropped to. The percentage change in WAT stock occurred in the recent session was 2.8% while the dollar amount for the price change in WAT stock was $10.01.
-
WAT's industry and sector of operation?
-
The NYSE listed WAT is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of WAT?
-
Daniel Rush | Senior Vice President of Global Research & Strategy
Amol Chaubal | Senior Vice President & Chief Financial Officer
Brook Colangelo | Senior VP & Chief Information Officer
Cheryl Kennedy | Senior Vice President of Human Resources
Jianqing Y. Bennett | Senior Vice President of Waters Advanced Diagnostics -
How many employees does WAT have?
-
Number of WAT employees currently stands at 7900. WAT operates from 34 Maple Street, Milford, MA 01757, US.
-
Link for WAT official website?
-
Official Website of WAT is: https://www.waters.com
-
How do I contact WAT?
-
WAT could be contacted at phone #508 478 2000 and can also be accessed through its website. WAT operates from 34 Maple Street, Milford, MA 01757, US.
-
How many shares of WAT are traded daily?
-
The average number of WAT shares traded daily for last 3 months was 1.02M.
-
What is the market cap of WAT currently?
-
The market value of WAT currently stands at $23.96B with its latest stock price at $367.55